• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶假尿嘧啶合成酶的C末端延伸是先天性角化不良的突变热点,可调节与端粒酶RNA的相互作用及亚细胞定位。

The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.

作者信息

Qin Jian, Garus Alexandre, Autexier Chantal

机构信息

Department of Anatomy and Cell Biology, McGill University, 3640 University Street, Montreal, Quebec, QC H3A 0C7, Canada.

Lady Davis Institute, Jewish General Hospital, 3755 Chem, de la Côte-Sainte-Catherine, Montréal, QC H3T 1E2, Canada.

出版信息

Hum Mol Genet. 2024 Feb 1;33(4):318-332. doi: 10.1093/hmg/ddad180.

DOI:10.1093/hmg/ddad180
PMID:37879098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10840380/
Abstract

Dyskerin is a component of the human telomerase complex and is involved in stabilizing the human telomerase RNA (hTR). Many mutations in the DKC1 gene encoding dyskerin are found in X-linked dyskeratosis congenita (X-DC), a premature aging disorder and other related diseases. The C-terminal extension (CTE) of dyskerin contributes to its interaction with the molecular chaperone SHQ1 during the early stage of telomerase biogenesis. Disease mutations in this region were proposed to disrupt dyskerin-SHQ1 interaction and destabilize dyskerin, reducing hTR levels indirectly. However, biochemical evidence supporting this hypothesis is still lacking. In addition, the effects of many CTE disease mutations on hTR have not been examined. In this study, we tested eight dyskerin CTE variants and showed that they failed to maintain hTR levels. These mutants showed slightly reduced but not abolished interaction with SHQ1, and caused defective binding to hTR. Deletion of the CTE further reduced binding to hTR, and perturbed localization of dyskerin to the Cajal bodies and the nucleolus, and the interaction with TCAB1 as well as GAR1. Our findings suggest impaired dyskerin-hTR interaction in cells as a previously overlooked mechanism through which dyskerin CTE mutations cause X-DC and related telomere syndromes.

摘要

端粒酶假尿嘧啶合成酶是人类端粒酶复合物的一个组成部分,参与稳定人类端粒酶RNA(hTR)。在X连锁先天性角化不良(X-DC)这一早衰性疾病及其他相关疾病中,发现了许多编码端粒酶假尿嘧啶合成酶的DKC1基因突变。端粒酶假尿嘧啶合成酶的C末端延伸(CTE)在端粒酶生物合成早期有助于其与分子伴侣SHQ1相互作用。该区域的疾病突变被认为会破坏端粒酶假尿嘧啶合成酶与SHQ1的相互作用,使端粒酶假尿嘧啶合成酶不稳定,从而间接降低hTR水平。然而,仍缺乏支持这一假设的生化证据。此外,许多CTE疾病突变对hTR的影响尚未得到研究。在本研究中,我们检测了8种端粒酶假尿嘧啶合成酶CTE变体,结果显示它们无法维持hTR水平。这些突变体与SHQ1的相互作用略有降低但并未消除,并导致与hTR的结合缺陷。CTE的缺失进一步降低了与hTR的结合,并扰乱了端粒酶假尿嘧啶合成酶在卡哈尔体和核仁中的定位,以及与TCAB1和GAR1的相互作用。我们的研究结果表明,细胞中端粒酶假尿嘧啶合成酶与hTR的相互作用受损是一种此前被忽视的机制,端粒酶假尿嘧啶合成酶CTE突变通过该机制导致X-DC和相关的端粒综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/2a61cf11ab63/ddad180f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/9b1ea52876df/ddad180ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/c5cd29ab07ed/ddad180f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/33a9a2342f5b/ddad180f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/13c25bf0682f/ddad180f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/b905778fbf57/ddad180f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/50cbcddf8358/ddad180f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/cb6c9b7f0aeb/ddad180f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/c3126144a323/ddad180f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/4c6782b75cf1/ddad180f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/2a61cf11ab63/ddad180f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/9b1ea52876df/ddad180ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/c5cd29ab07ed/ddad180f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/33a9a2342f5b/ddad180f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/13c25bf0682f/ddad180f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/b905778fbf57/ddad180f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/50cbcddf8358/ddad180f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/cb6c9b7f0aeb/ddad180f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/c3126144a323/ddad180f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/4c6782b75cf1/ddad180f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb21/10840380/2a61cf11ab63/ddad180f9.jpg

相似文献

1
The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.端粒酶假尿嘧啶合成酶的C末端延伸是先天性角化不良的突变热点,可调节与端粒酶RNA的相互作用及亚细胞定位。
Hum Mol Genet. 2024 Feb 1;33(4):318-332. doi: 10.1093/hmg/ddad180.
2
N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.人端粒酶 RNA 结合蛋白 dyskerin 的 N 端残基对于防止 RNA 降解的相互作用是必需的。
Nucleic Acids Res. 2019 Jun 4;47(10):5368-5380. doi: 10.1093/nar/gkz233.
3
Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.人端粒酶RNA与戴斯凯林蛋白相互作用的单分子分析及先天性角化不良突变的影响
Biochemistry. 2009 Nov 24;48(46):10858-65. doi: 10.1021/bi901373e.
4
Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.先天性角化不良突变导致核仁素 SUMOylation 保守位点缺陷,从而导致端粒酶 RNA 积累减少和端粒缺陷。
Hum Mol Genet. 2013 Sep 1;22(17):3498-507. doi: 10.1093/hmg/ddt204. Epub 2013 May 8.
5
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.端粒酶组分NHP2的突变会导致早衰综合征先天性角化不良。
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8073-8. doi: 10.1073/pnas.0800042105. Epub 2008 Jun 3.
6
Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.在常染色体显性遗传性角化不良中发生突变的端粒酶RNA可重建一种在端粒延长方面存在缺陷的弱活性端粒酶。
Cell Cycle. 2005 Apr;4(4):585-9. Epub 2005 Apr 3.
7
Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.X 连锁先天性角化不良中端粒缩短的机制是 dyskerin 水平降低。
J Med Genet. 2011 May;48(5):327-33. doi: 10.1136/jmg.2010.085100. Epub 2011 Mar 17.
8
Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.X 连锁先天性角化不良(DKCX)细胞缺陷的严重程度与核糖体 RNA 生物发生或 mRNA 翻译中核蛋白(DKC1)的活性没有直接关系。
Hum Mutat. 2013 Dec;34(12):1698-707. doi: 10.1002/humu.22447. Epub 2013 Oct 21.
9
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.先天性角化不良诱导多能干细胞中端粒缩短和自我更新能力丧失。
Nature. 2011 May 22;474(7351):399-402. doi: 10.1038/nature10084.
10
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.端粒酶核糖核蛋白的积累而非其特异性活性决定了 X 连锁先天性角化不良的端粒维持缺陷。
Hum Mol Genet. 2012 Feb 15;21(4):721-9. doi: 10.1093/hmg/ddr504. Epub 2011 Nov 4.

引用本文的文献

1
Identification and Computational Analysis of a Novel Pathogenic DKC1 Variant Underlying X-Linked Dyskeratosis Congenita.X连锁先天性角化不良潜在的一种新型致病性DKC1变异体的鉴定与计算分析
Biochem Genet. 2025 Jul 9. doi: 10.1007/s10528-025-11187-z.
2
Interprotomer Communication and Functional Asymmetry in H/ACA snoRNPs.H/ACA 小核仁核糖核蛋白中的亚基间通讯与功能不对称性
bioRxiv. 2025 Jun 8:2025.06.07.658439. doi: 10.1101/2025.06.07.658439.
3
Advancements in pseudouridine modifying enzyme and cancer.假尿苷修饰酶与癌症的进展

本文引用的文献

1
Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity.新型 NHP2 病理性变异影响 N 端结构域的灵活性、蛋白稳定性、H/ACA 核糖核蛋白(RNP)复合物形成和端粒酶活性。
Hum Mol Genet. 2023 Sep 16;32(19):2901-2912. doi: 10.1093/hmg/ddad114.
2
Proteomic analyses reveal new features of the box H/ACA RNP biogenesis.蛋白质组分析揭示了 box H/ACA RNP 生物发生的新特征。
Nucleic Acids Res. 2023 Apr 24;51(7):3357-3374. doi: 10.1093/nar/gkad129.
3
Structure of active human telomerase with telomere shelterin protein TPP1.
Front Cell Dev Biol. 2024 Dec 16;12:1465546. doi: 10.3389/fcell.2024.1465546. eCollection 2024.
活性人端粒酶与端粒保护蛋白 TPP1 的结构。
Nature. 2022 Apr;604(7906):578-583. doi: 10.1038/s41586-022-04582-8. Epub 2022 Apr 13.
4
Structure of human telomerase holoenzyme with bound telomeric DNA.人端粒酶全酶与结合的端粒 DNA 的结构。
Nature. 2021 May;593(7859):449-453. doi: 10.1038/s41586-021-03415-4. Epub 2021 Apr 21.
5
Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization.塑造人类端粒:从端粒保护蛋白和 CST 复合物到端粒染色质结构。
Nat Rev Mol Cell Biol. 2021 Apr;22(4):283-298. doi: 10.1038/s41580-021-00328-y. Epub 2021 Feb 9.
6
SUMOylation- and GAR1-Dependent Regulation of Dyskerin Nuclear and Subnuclear Localization.SUMOylation-和 GAR1 依赖性调节核仁蛋白 dyskerin 的核内和亚核定位。
Mol Cell Biol. 2021 Mar 24;41(4). doi: 10.1128/MCB.00464-20.
7
The end protection problem-an unexpected twist in the tail.末端保护问题——意料之外的转折。
Genes Dev. 2021 Jan 1;35(1-2):1-21. doi: 10.1101/gad.344044.120. Epub 2020 Dec 23.
8
Regulation of human telomerase RNA biogenesis and localization.调控人类端粒酶 RNA 的生物发生和定位。
RNA Biol. 2021 Mar;18(3):305-315. doi: 10.1080/15476286.2020.1809196. Epub 2020 Sep 2.
9
Regulation of human telomerase in homeostasis and disease.人类端粒酶在体内平衡和疾病中的调控。
Nat Rev Mol Cell Biol. 2020 Jul;21(7):384-397. doi: 10.1038/s41580-020-0234-z. Epub 2020 Apr 2.
10
Nascent Pre-rRNA Sorting via Phase Separation Drives the Assembly of Dense Fibrillar Components in the Human Nucleolus.通过相分离对初生 pre-rRNA 进行分拣,从而驱动人核仁中致密纤维组分的组装。
Mol Cell. 2019 Dec 5;76(5):767-783.e11. doi: 10.1016/j.molcel.2019.08.014. Epub 2019 Sep 17.